Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF

British Journal of Cancer

Volumn 84, Issue 9, 2001, Pages 1252-1257

  Im, S A ^a   Kim, J S ^b   Gomez Manzano, C ^c   Fueyo, J ^c   Liu, T J ^c   Cho, M S ^d   Seong, C M ^a   Lee, S N ^a   Hong, Y K ^e   Yung, W K A ^c  

^a Departments of Internal Medicine   (United States)

^b General Surgery   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d Ewha Womans University School of Medicine   (South Korea)

^e The Catholic University of Korea   (South Korea)

Author keywords

Adenovirus; Antiangiogenesis; Breast cancer; Gene therapy; VEGF

Indexed keywords

COMPLEMENTARY DNA; VASCULOTROPIN; VIRUS VECTOR;

ADENOVIRUS; ANGIOGENESIS; ANIMAL MODEL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER INHIBITION; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR GROWTH;

ADENOVIRIDAE; ANGIOGENESIS INHIBITORS; ANTISENSE ELEMENTS (GENETICS); BREAST NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; TRANSFECTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 17844398957     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1734     Document Type: Article

References (23)

1. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor 121
2. Immunology of spontaneous mammary carcinomas in mice. V: Acquired tumor resistance and enhancement in strain of mice infected with mammary tumor virus
3. Antiangiogeneic therapy of experimental cancer does not induce acquired drug resistance
4. Tumor interactions with the vasculature: Angiogenesis and tumor metastasis
5. Suppression of glioblastoma angiogenicity and tumorigenicity by inhibition of endogeneous expression of vascular endothelial growth factor
6. Vascular permeability factor/vascular endothelial growth factor: An important mediator of angiogenesis in malignancy and inflammation
7. Angiogenesis and breast cancer
8. Adenovirus - Mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis
9. Manipulation of adenovirus vectors
10. Tumor angiogenesis as a predictor of prognosis in gastric carcinoma
11. Antiangiogenesis treatment for gliomas: Transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo
12. An adenovirus type 5 early gene function regulates expression of other early viral genes
13. A novel approach to glioma gene therapy: Down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes
14. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo
15. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence
16. Role of VEGF-Flt receptor system in normal and tumor angiogenesis
17. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
18. Viral vector - Targeted antigangiogenic gene therapy utilizing an angiostatin complementary DNA
19. Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
20. Tumor angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma
21. Expression of vascular endothelial growth factor, its receptor, and other angiogenic factor in human breast cancer
22. Vascular endothelial growth factor is essential for initial but not continued in vivo growth of human breast carcinoma cells
23. Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis